Hilverding Austin T, DiPietro Mager Natalie A
J Am Pharm Assoc (2003). 2017 Jul-Aug;57(4):493-497. doi: 10.1016/j.japh.2017.04.464. Epub 2017 Jun 12.
The primary objective was to assess attitudes from Ohio pharmacists about contraceptive authority. Secondary objectives included determining pharmacists' perceptions of benefits, barriers, and preparedness for offering such services and examining attitudes about and experiences with other reproductive health topics to inform future research.
An anonymous 26-question Institutional Review Board-approved electronic survey was developed and distributed via Qualtrics to a random sample of 500 licensed pharmacists in Ohio. Two months were allotted for survey completion. A link to free Accreditation Council for Pharmacy Education-approved continuing pharmacy education (CPE) through Ohio Northern University was offered as an incentive for completing the survey.
One hundred thirty-eight pharmacists completed the survey (62% female). Fifty-eight percent worked in community pharmacy and 34% in health-system pharmacy. The majority indicated that oral and transdermal contraceptive methods should be pharmacist-initiated (57% and 54%, respectively) through a collaborative practice agreement or statewide protocol. More pharmacists supported provision of hormonal contraception through a collaborative practice agreement rather than a statewide protocol. Increased access to care and convenience for patients were identified most frequently as potential benefits. Time constraints, concerns of increased liability, and other barriers for initiating such services were identified by pharmacists. Pharmacists most frequently listed clinical guidelines, CPE, and patient education materials as tools needed to successfully initiate contraceptive therapy regimens. Pharmacists responding to the survey were also proponents of increasing involvement in other aspects of sexual and reproductive health, such as expedited partner therapy (64%) and human papilloma virus vaccination (67%). Respondents indicated a potential lack of experience or training in topics such as expedited partner therapy and intimate partner violence.
Pharmacists surveyed showed interest in providing sexual and reproductive health services, including pharmacist-provided prescription contraceptive products and preventive health services. Further studies are needed to evaluate pharmacists' roles in other sexual and reproductive health services.
主要目的是评估俄亥俄州药剂师对避孕授权的态度。次要目的包括确定药剂师对提供此类服务的益处、障碍和准备情况的看法，并调查对其他生殖健康主题的态度和经历，以为未来研究提供信息。
开发了一份经机构审查委员会批准的26个问题的匿名电子调查问卷，并通过Qualtrics分发给俄亥俄州500名持牌药剂师的随机样本。分配两个月时间完成调查。提供通过俄亥俄北方大学获得药学教育认证委员会批准的免费继续药学教育（CPE）链接作为完成调查的激励措施。
138名药剂师完成了调查（62%为女性）。58%在社区药房工作，34%在医疗系统药房工作。大多数人表示，口服和透皮避孕方法应通过合作实践协议或全州范围的方案由药剂师发起（分别为57%和54%）。更多药剂师支持通过合作实践协议而非全州范围的方案提供激素避孕。增加患者获得护理的机会和便利性被最频繁地确定为潜在益处。药剂师指出了时间限制、对责任增加的担忧以及启动此类服务的其他障碍。药剂师最常将临床指南、CPE和患者教育材料列为成功启动避孕治疗方案所需的工具。参与调查的药剂师也支持更多地参与性与生殖健康的其他方面，如加速性伴侣治疗（64%）和人乳头瘤病毒疫苗接种（67%）。受访者表示在加速性伴侣治疗和亲密伴侣暴力等主题上可能缺乏经验或培训。
接受调查的药剂师对提供性与生殖健康服务表现出兴趣，包括药剂师提供的处方避孕产品和预防性健康服务。需要进一步研究来评估药剂师在其他性与生殖健康服务中的作用。
